FUNDAMENTAL AND TECHNICAL.
An effective cure for hepatitis have sent
one of the world's most well-run
pharmaceutical company Gilead Sciences
on sale The medication works, patients
become well, and everyone should be happy.
But the problem is that the medication works to well
and patients doesn't need the medication further
after the treatment. and this can harm the revenue
for the company.
THE TECHNICAL
The E-P-S (earnings pr share) is actually pretty
high at 9.94. The P-E(Price Ernings) Ratio is at 6.94
so investors are willing to pay 6,94 Dollar
pr dollar ernings. where the E-P-S is at 9,94
the dividend yield is at 2,97%
therefore
Gilead sciences dividend payout ratio is
= 2,97/(1/6,94)= 20,61 %
So the dividend payout ratio is really high and
we could se an increase in the stock at 20,61%
that is an increase of 14,28 Dollars pr share.
i will be updating this in the comment with more fundamentals.
An effective cure for hepatitis have sent
one of the world's most well-run
pharmaceutical company Gilead Sciences
on sale The medication works, patients
become well, and everyone should be happy.
But the problem is that the medication works to well
and patients doesn't need the medication further
after the treatment. and this can harm the revenue
for the company.
THE TECHNICAL
The E-P-S (earnings pr share) is actually pretty
high at 9.94. The P-E(Price Ernings) Ratio is at 6.94
so investors are willing to pay 6,94 Dollar
pr dollar ernings. where the E-P-S is at 9,94
the dividend yield is at 2,97%
therefore
Gilead sciences dividend payout ratio is
= 2,97/(1/6,94)= 20,61 %
So the dividend payout ratio is really high and
we could se an increase in the stock at 20,61%
that is an increase of 14,28 Dollars pr share.
i will be updating this in the comment with more fundamentals.